Literature DB >> 17944272

Human coronaviruses: what do they cause?

Lia van der Hoek1.   

Abstract

SARS-CoV, human coronavirus NL63 (HCoV-NL63) and HCoV-HKU1 were first described in 2003, 2004 and 2005 respectively. Nevertheless, discovery of three new human coronaviruses does not necessary represent a sudden increase in emerging infections by new coronaviruses. Only SARS-CoV has recently been introduced to the human population; the other two have been circulating in humans for a long time. HCoV-HKU1 and HCoV-NL63 are respiratory coronaviruses, are frequently found during lower and upper respiratory tract infections, have spread worldwide, and prefer the winter season. These characteristics do not differ greatly from the symptoms described for the 'old' viruses HCoV-229E and HCoV-OC43. This report presents an overview of the current knowledge of the four human coronavirus that are now circulating in the human population.

Entities:  

Mesh:

Year:  2007        PMID: 17944272

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  130 in total

1.  Genome-Wide Screen Reveals Valosin-Containing Protein Requirement for Coronavirus Exit from Endosomes.

Authors:  Hui Hui Wong; Pankaj Kumar; Felicia Pei Ling Tay; Dimitri Moreau; Ding Xiang Liu; Frédéric Bard
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.

Authors:  Adriaan H de Wilde; Kazimier F Wannee; Florine E M Scholte; Jelle J Goeman; Peter Ten Dijke; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi.

Authors:  Thomas K Hartung; Daniel Chimbayo; Joep J G van Oosterhout; Tarsizio Chikaonda; Gerard J J van Doornum; Eric C J Claas; Willem J G Melchers; Malcolm E Molyneux; Ed E Zijlstra
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 4.  Multi-Scale Airborne Infectious Disease Transmission.

Authors:  Charles F Dillon; Michael B Dillon
Journal:  Appl Environ Microbiol       Date:  2020-12-04       Impact factor: 4.792

5.  Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2.

Authors:  Jessica K Roth-Cross; Helen Stokes; Guohui Chang; Ming Ming Chua; Volker Thiel; Susan R Weiss; Alexander E Gorbalenya; Stuart G Siddell
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 6.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism.

Authors:  Ronald Dijkman; Maarten F Jebbink; Sylvie M Koekkoek; Martin Deijs; Hulda R Jónsdóttir; Richard Molenkamp; Margareta Ieven; Herman Goossens; Volker Thiel; Lia van der Hoek
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

8.  Human coronaviruses are uncommon in patients with gastrointestinal illness.

Authors:  Frank Esper; Zhen Ou; Yung T Huang
Journal:  J Clin Virol       Date:  2010-04-01       Impact factor: 3.168

9.  Understanding Human Coronavirus HCoV-NL63.

Authors:  Sahar Abdul-Rasool; Burtram C Fielding
Journal:  Open Virol J       Date:  2010-05-25

10.  Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2.

Authors:  Alison C Mathewson; Alexandra Bishop; Yongxiu Yao; Fred Kemp; Junyuan Ren; Hongying Chen; Xiaodong Xu; Ben Berkhout; Lia van der Hoek; Ian M Jones
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.